Article: Nicotinamide Riboside Improves Mitophagy and Reduces Neuroinflammation in Ataxia Telangiectasia: Preclinical Findings

PrevNext
Ataxia Telangiectasia Mitochondrial Health Neurological Health Preclinical

Nicotinamide Riboside Improves Mitophagy and Reduces Neuroinflammation in Ataxia Telangiectasia: Preclinical Findings

Synopsis

In the premature aging disease ataxia telangiectasia (A-T), cells show mitochondrial dysfunction and a senescence state that causes inflammation (SASP). This is linked to buildup of damaged mitochondria and DNA in the cell cytoplasm, activating inflammatory pathways via STING. Boosting NAD+ with nicotinamide riboside (NR) helps clear damaged mitochondria through mitophagy, which depends on the protein PINK1. NR treatment reduced brain inflammation, prevented nerve cell loss, and improved movement in A-T mice. This suggests that fixing mitochondrial problems by increasing mitophagy with NR could be a therapy for A-T and related aging conditions.

Journal

Aging Cell

Share

Read more

Liver Health

Nicotinamide Riboside Increased Liver Regeneration by Enhancing Mitochondrial Functions: Preclinical Findings

Synopsis The liver’s ability to regenerate after injury or surgery is vital for survival, but the metabolic mechanisms behind this process are not fully understood. This study found that losing th...

Read more
Healthy Aging & Longevity

17-α-Estradiol Extends Male Mouse Lifespan, While Nicotinamide Riboside Shows No Significant Effect: Preclinical Findings

SynopsisIn genetically diverse mice, the “non-feminizing” estrogen 17-α-estradiol (17aE2) increased median male lifespan by 19% when started at 16 months and by 11% when started at 20 months. It al...

Read more